- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05482165
Optimizing Intervention Effects in Children and Adolescents
Optimizing Intervention Effects in Children and Adolescents in Ningbo City
Childhood obesity is a significant public health concern worldwide. In China, childhood obesity has dramatically increased as the economy has grown quickly over the past decades. Effective strategies to reduce childhood obesity prevalence may help to prevent related chronic diseases in the whole population in the long term.
This study aimed (1)to assess the effectiveness of the intervention compared with the usual practice in preventing childhood overweight and obesity; (2) to determine the sustainability of the intervention in preventing overweight and obesity; and (3) to evaluate the process and health economics of the intervention.
The project will be carried out in six primary schools in Ningbo City, Zhejiang Province , those schools are randomly divided into two groups: the intervention group and the usual practice group. The participants of the study were students in the third grade of primary school, and the intervention will last for one academic year. This intervention programme will target the influencing factors of childhood obesity at both individual (student-focused activities) and environmental levels (a supportive family and school environment), with the intent to influence the knowledge, attitude and behaviours of school children.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ningbo, China
- Ningbo First Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Parents agree and support their children's weight loss, and students and parents have informed consent;
- Students in third grade aged 8 to 10 years old.
Exclusion Criteria:
- medical history of heart disease, hypertension, diabetes, tuberculosis, asthma, hepatitis or nephritis;
- obesity caused by endocrine diseases or side effects of drugs;
- abnormal physical development like dwarfism or gigantism;
- physical deformity such as severe scoliosis, pectus carinatum, limp, obvious O-leg or X-leg;
- inability to participate in school sport activities;
- a loss in weight by vomiting or taking drugs during the past 3 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
The students of this group will receive multi-faceted intervention activities toward weight management.
|
This intervention programme will target the influencing factors of childhood obesity to influence the knowledge, attitude and behaviours of school children. Students in the intervention group will receive the following interventions:
|
|
No Intervention: Usual practice group
The students of this group will receive regular health education.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in body mass index (BMI)
Time Frame: 9months , 24 months and 36 months
|
|
9months , 24 months and 36 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in blood glucose
Time Frame: 9 months
|
caculated by terminal value minus baseline value
|
9 months
|
|
change in blood lipids
Time Frame: 9 months
|
|
9 months
|
|
change in fasting insulin
Time Frame: 9 months
|
caculated by terminal value minus baseline value
|
9 months
|
|
change in body fat percentage
Time Frame: 9 months
|
caculated by terminal value minus baseline value
|
9 months
|
|
change in BMI z- score
Time Frame: 9months , 24 months and 36 months
|
|
9months , 24 months and 36 months
|
|
change in waist circumference
Time Frame: 9 months, 24 months and 36 months
|
caculated by terminal value minus baseline value
|
9 months, 24 months and 36 months
|
|
change in weight
Time Frame: 9months, 24 months and 36 months
|
caculated by terminal value minus baseline value
|
9months, 24 months and 36 months
|
|
change in cardiorespiratory endurance test
Time Frame: 9 months, 24 months and 36 months
|
caculated by terminal value minus baseline value
|
9 months, 24 months and 36 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-R168
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Obesity
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Universidad de SonoraCentro de Investigación en Alimentación y Desarrollo A.C.; Instituto Nacional...Not yet recruitingChildhood Obesity Pevention
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaCompletedPrevention Childhood ObesityMexico
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
Clinical Trials on Multi-faceted health promotion programme
-
Assistance Publique - Hôpitaux de ParisRecruitingGrief Disorder, ProlongedFrance
-
University of Lausanne HospitalsCompletedDiabetes | Rheumatoid ArthritisSwitzerland
-
Medical University InnsbruckTiroler Landeskrankenanstalten GmbH (TILAK); Tiroler Gebietskrankenkasse (TGKK) and other collaboratorsCompletedAtherosclerosis | Life StyleAustria, Italy
-
Little Lions Child CoachingKing's College London; University of Cape TownActive, not recruitingPsychological Well-BeingSouth Africa
-
University of TorontoAlberta Health servicesCompletedVaccine Adverse Reaction | Fear | Vaccination; ComplicationsCanada
-
The University of Hong KongCompleted
-
Fangbiao TaoNot yet recruitingMyopia | Mental Health | Cardiovascular Health Status
-
Johns Hopkins UniversityWestat; Baltimore CONNECT; Coaching Salud Holistica; La Clinica del Pueblo; Rivera... and other collaboratorsActive, not recruitingHypertension | Diabetes | Overweight and Obesity | Pre-diabetesUnited States
-
University of TorontoTerminatedVaccine Adverse Reaction | Fear | Vaccination; ComplicationsCanada
-
University of TorontoUnknownImmunisation Anxiety Related ReactionCanada